Glyphic Biotechnologies

Glyphic Biotechnologies is a privately held, Berkeley, California-based biotechnology company developing a next-generation protein sequencing platform. Scientifically, they focus on decoding the human proteome at single-molecule resolution using their proprietary Protein Sequencing by Expansion (ProSE™) technology. This massively parallel approach physically expands molecules to accurately discriminate all 20 amino acids and post-translational modifications, overcoming the throughput limits of traditional mass spectrometry.